FUNDING
Medical device and diagnostics companies are always looking for ways to improve their products and services. In the ever-changing landscape of the healthcare industry, it’s essential for these companies to stay ahead of the curve. That’s why funding is always news.
Series A, B, and other rounds of funding are essential for medical device and diagnostics companies. They provide the necessary capital to help these businesses grow and innovate. And with so many investors interested in this space, there are plenty of opportunities for companies to secure the funding they need.
SELUTION SLR Enrollment of 4 Clinical Studies to Commence: MedAlliance Raises over USD 50 Million from New Investor
The new investor is Trustar Capital (formerly known as CITIC Capital Partners).
Belmont Medical Technologies Receives $221K in Training Grant via via the Commonwealth of Massachusetts’ Workforce Training Fund Program
Belmont Medical Technologies currently employs 187 associates, including 137 in Massachusetts.
TechsoMed Raises $7 Million Series B Financing: Funding to Support Company’s Pursuit of FDA Approval & Commercialization Readiness
Following clinical and regulatory approval, the company's technology has the potential to help physicians ensure treatment accuracy and increase treatment efficacy.
Oxular Raises $37 Million
Proceeds will fund planned further clinical development of its lead asset, OXU-001, for the treatment of diabetic macular edema (DME), as well as accelerating the development of its early-product pipeline.
Nemaura Medical Secures $20 Million Non-Dilutive Non-convertible Loan to Accelerate Growth
Nemaura Medical is a medical technology company developing and commercializing non-invasive wearable diagnostic devices.
Q’Apel Medical Raises $22 Million: Funds Will Help Grow a Highly Innovative Neurovascular Access Platform
In addition, Q'Apel Medical reported that Scott Huennekens, former Chairman, CEO and President of Verb Surgical, and Carter McNabb, Managing Director, River Cities Capital, will join the Board of Directors.
Huami Corp Invests $5 Million in Hyperfine Research D Round
Huami corporate mission is to connect health with technology, developing both consumer and industrial health technologies.
Minnetronix Medical Announces Recapitalization with Altaris Capital Partners
CEO Jeremy Maniak said, “Throughout our relationship with Altaris, we have achieved many milestones as a company. Now, with our expanded partnership, we are excited to accelerate our strategy and move into the next stage of growth at Minnetronix.”
Transit Scientific Announces the Close of Its Series A financing Round
The company achieved FDA clearances and multi-center, multi-user, safe-patient-use of its XO Score angioplasty scoring-cutting platform and separate XO Cross 0.014" and 0.035" microcatheter platform in late 2020.
Medical Device News Magazine
